Dr.Ahmad

Post-Exposure Prophylaxis (PEP)

RM699.00

HIV Post-Exposure Prophylaxis (PEP) is an emergency treatment used after potential exposure to HIV to reduce the risk of infection. It involves a combination of antiretroviral medications that work by preventing the virus from multiplying and establishing infection in the body.

PEP must be started as soon as possible after exposure to be effective.
Emergency HIV Protection – Act Within 72 Hours

PEP (Post-Exposure Prophylaxis) is an emergency treatment that helps prevent HIV infection after potential exposure. It must be started as soon as possible (within 72 hours) for maximum effectiveness.

If you think you may have been exposed, do not delay.

Key Benefits

✔ Significantly reduces risk of HIV after exposure
✔ Most effective when started early
✔ Doctor-guided treatment for safety
✔ Proven and widely used emergency protocol

What You Get
  • FREE Doctor Consultation (Urgent Assessment)
  • Immediate treatment guidance
  • FREE HIV Rapid Test
  • Full course medication
  • Follow-up advice & care

Remarks:The image is for illustration purposes only. The actual product comes with branded packaging and proper labeling.

Who Should Take HIV PEP?

PEP is recommended after potential high-risk exposure to HIV, including:

  • Unprotected sexual contact with a partner of unknown or positive HIV status
  • Condom break or failure during intercourse
  • Needle-stick injury or sharing needles
  • Sexual assault
How to Take HIV PEP
  • Take 1 dose once daily for 28 consecutive days
  • Start treatment as soon as possible (ideally within 2 hours, and no later than 72 hours after exposure)
  • Strict adherence is essential for effectiveness

If you miss a dose:

  • Take it as soon as you remember
  • If it is close to your next dose, skip the missed dose
  • Do not take a double dose
Side Effects of HIV PEP

PEP is generally well tolerated, though some individuals may experience temporary side effects.

Common side effects:

  • Nausea
  • Fatigue
  • Headache
  • Diarrhea

These usually improve within a few days to weeks.

Less common but important side effects:

  • Kidney function changes
  • Sleep disturbances (associated with dolutegravir)
How to Manage Side Effects
  • Take medication with food to reduce nausea
  • Maintain adequate hydration
  • Take medication at a consistent time daily
  • Seek medical advice if symptoms persist or worsen
Conclusion

HIV PEP is a time-sensitive, highly effective intervention that can significantly reduce the risk of HIV infection after potential exposure. Early initiation and full adherence to the 28-day regimen are critical for success.

Seek medical attention immediately if exposure is suspected.

Each regimen contains:

Tenofovir disoproxil fumarate 300 mg, Emtricitabine 200 mg, Dolutegravir 50 mg

How to Take HIV PEP

  1. Take 1 dose once daily for 28 consecutive days
  2. Start treatment as soon as possible (ideally within 2 hours, and no later than 72 hours after exposure)
  3. Strict adherence is essential for effectiveness

If you miss a dose:

  • Take it as soon as you remember
  • If it is close to your next dose, skip the missed dose

Do not take a double dose

Frequently Asked Questions (FAQs)

Frequently Asked Questions (FAQs)

1. How effective is HIV PEP?

PEP can reduce the risk of HIV infection by more than 80–90% when:

  • Started early
  • Taken correctly for the full 28 days

PEP should be started:

  • Immediately (ideally within 2 hours)
  • No later than 72 hours after exposure

After 72 hours, effectiveness is significantly reduced.

No. PEP only protects against HIV.
Condom use and STI screening are still important.

Yes. Follow-up is essential:

  • Baseline HIV test before starting
  • Repeat testing at 6 weeks and 3 months
  • Additional monitoring if required

No. PEP is for emergency use only.
If you have ongoing risk, consider switching to HIV PrEP.

Prescription Requirement

This medication is available only with a valid prescription.We offer a complimentary e-prescription service, subject to clinical eligibility.
Scroll to Top
0